New Drugs for Rare Diseases

Joyce talks with Marlene Haffner, retired Admiral in the US Public Health Service. Dr. Haffner served as Director of the Office of Orphan Product Development at the US Food and Drug Administration (FDA) for 20 years. Having worked as a physician provider of medical care, a regulator, and in product development, she has a unique perspective on the development of orphan drugs.